Crook T - Search Results

1

DRAM, a p53-induced modulator of autophagy, is critical for apoptosis.

Crighton D, Wilkinson S, O'Prey J, Syed N, Smith P, Harrison PR, Gasco M, Garrone O, Crook T, Ryan KM. Crighton D, et al. Among authors: crook t. Cell. 2006 Jul 14;126(1):121-34. doi: 10.1016/j.cell.2006.05.034. Cell. 2006. PMID: 16839881 Free article.

2

The p53 network in head and neck cancer.

Gasco M, Crook T. Gasco M, et al. Among authors: crook t. Oral Oncol. 2003 Apr;39(3):222-31. doi: 10.1016/s1368-8375(02)00163-x. Oral Oncol. 2003. PMID: 12618194 Review.

3

p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis.

Bergamaschi D, Gasco M, Hiller L, Sullivan A, Syed N, Trigiante G, Yulug I, Merlano M, Numico G, Comino A, Attard M, Reelfs O, Gusterson B, Bell AK, Heath V, Tavassoli M, Farrell PJ, Smith P, Lu X, Crook T. Bergamaschi D, et al. Among authors: crook t. Cancer Cell. 2003 Apr;3(4):387-402. doi: 10.1016/s1535-6108(03)00079-5. Cancer Cell. 2003. PMID: 12726864 Free article.

4

p53 family members and chemoresistance in cancer: what we know and what we need to know.

Gasco M, Crook T. Gasco M, et al. Among authors: crook t. Drug Resist Updat. 2003 Dec;6(6):323-8. doi: 10.1016/j.drup.2003.11.001. Drug Resist Updat. 2003. PMID: 14744496 Review.

5

Epigenetic inactivation implies a tumor suppressor function in hematologic malignancies for Polo-like kinase 2 but not Polo-like kinase 3.

Smith P, Syed N, Crook T. Smith P, et al. Among authors: crook t. Cell Cycle. 2006 Jun;5(12):1262-4. doi: 10.4161/cc.5.12.2813. Cell Cycle. 2006. PMID: 16868416

6

Epigenetic inactivation implies independent functions for insulin-like growth factor binding protein (IGFBP)-related protein 1 and the related IGFBPL1 in inhibiting breast cancer phenotypes.

Smith P, Nicholson LJ, Syed N, Payne A, Hiller L, Garrone O, Occelli M, Gasco M, Crook T. Smith P, et al. Among authors: crook t. Clin Cancer Res. 2007 Jul 15;13(14):4061-8. doi: 10.1158/1078-0432.CCR-06-3052. Clin Cancer Res. 2007. PMID: 17634530

7

Identification of CDK10 as an important determinant of resistance to endocrine therapy for breast cancer.

Iorns E, Turner NC, Elliott R, Syed N, Garrone O, Gasco M, Tutt AN, Crook T, Lord CJ, Ashworth A. Iorns E, et al. Among authors: crook t. Cancer Cell. 2008 Feb;13(2):91-104. doi: 10.1016/j.ccr.2008.01.001. Cancer Cell. 2008. PMID: 18242510 Free article.

8

Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter.

Hannigan A, Smith P, Kalna G, Lo Nigro C, Orange C, O'Brien DI, Shah R, Syed N, Spender LC, Herrera B, Thurlow JK, Lattanzio L, Monteverde M, Maurer ME, Buffa FM, Mann J, Chu DC, West CM, Patridge M, Oien KA, Cooper JA, Frame MC, Harris AL, Hiller L, Nicholson LJ, Gasco M, Crook T, Inman GJ. Hannigan A, et al. Among authors: crook t. J Clin Invest. 2010 Aug;120(8):2842-57. doi: 10.1172/JCI36125. Epub 2010 Jul 1. J Clin Invest. 2010. PMID: 20592473 Free PMC article.

9

The p53 pathway in breast cancer.

Gasco M, Shami S, Crook T. Gasco M, et al. Among authors: crook t. Breast Cancer Res. 2002;4(2):70-6. doi: 10.1186/bcr426. Epub 2002 Feb 12. Breast Cancer Res. 2002. PMID: 11879567 Free PMC article. Review.

10

iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53.

Bergamaschi D, Samuels Y, Sullivan A, Zvelebil M, Breyssens H, Bisso A, Del Sal G, Syed N, Smith P, Gasco M, Crook T, Lu X. Bergamaschi D, et al. Among authors: crook t. Nat Genet. 2006 Oct;38(10):1133-41. doi: 10.1038/ng1879. Epub 2006 Sep 10. Nat Genet. 2006. PMID: 16964264

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

380 results

Search Page